GERGEN MARK J (President and CBO) reported 1 transaction at POSEIDA THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 2/3/2023ACC: 0001209191-23-006818
DirectorOfficer· President and CBO
Since Jul 2020
-31.82K
Net shares
Net seller
$222.7K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
31.82K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−31.82K
Price / share
$7.00
Trade value
$222.73K
% of position
8.8%
2/1/2023
362.13K→330.31K
Total
Net shares
−31.82K
Net value
-$222.73K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/1/2023 | F · Tax Withholding | −31.82K | $7.00 | $222.73K | 8.8% | 362.13K | 330.31K |
| Total | −31.82K | -$222.73K | ||||||
Derivative Transactions0
No derivative transactions reported